Encompass Health Sees FY24 Adj. EPS $3.86-$4.11 Vs $3.97 Est.; Revenue $5.250B-$4.325B Vs $5.261B Est.
Portfolio Pulse from Benzinga Newsdesk
Encompass Health projects its FY24 adjusted EPS to be between $3.86 and $4.11, compared to the estimated $3.97. The company anticipates revenue to range from $5.250 billion to $4.325 billion, slightly below the estimated $5.261 billion.
April 24, 2024 | 8:29 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Encompass Health's FY24 earnings and revenue projections are slightly below analyst estimates, indicating a cautious outlook.
Encompass Health's projected adjusted EPS and revenue for FY24 are both slightly below analyst expectations, which could lead to a negative short-term impact on the stock price. The company's cautious outlook, especially with revenue projections not meeting the estimated figures, may concern investors about potential growth challenges.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100